On the methodology of drug trials in migraine with aura

Anne Werner Hauge; Anders Hougaard; Jes Olesen

doi:10.1177/0333102409359091

On the methodology of drug trials in migraine with aura

Anne Werner Hauge, Anders Hougaard, Jes Olesen

Department of Neurology

9 Citations (Scopus)

Abstract

INTRODUCTION: Specific problems occur in clinical treatment trials for migraine with aura that differ from those encountered in treatment trials for migraine without aura. DISCUSSION: Based on our experience with four such trials, we point to a number of possible solutions and outline areas for future inquiry. We make recommendations about subject selection; the choice, definition and assessment of outcome measures; optimal treatments in relation to aura and headache; and we provide samples of study report forms used to record occurrence of aura and headache in this population.

Original language	English
Journal	Cephalalgia
Volume	30
Issue number	9
Pages (from-to)	1041-8
Number of pages	8
ISSN	0333-1024
DOIs	https://doi.org/10.1177/0333102409359091
Publication status	Published - 1 Sept 2010

Access to Document

10.1177/0333102409359091

Cite this

@article{511c7b8d837046d6a548634589269053,

title = "On the methodology of drug trials in migraine with aura",

abstract = "INTRODUCTION: Specific problems occur in clinical treatment trials for migraine with aura that differ from those encountered in treatment trials for migraine without aura. DISCUSSION: Based on our experience with four such trials, we point to a number of possible solutions and outline areas for future inquiry. We make recommendations about subject selection; the choice, definition and assessment of outcome measures; optimal treatments in relation to aura and headache; and we provide samples of study report forms used to record occurrence of aura and headache in this population.",

author = "Hauge, {Anne Werner} and Anders Hougaard and Jes Olesen",

year = "2010",

month = sep,

day = "1",

doi = "10.1177/0333102409359091",

language = "English",

volume = "30",

pages = "1041--8",

journal = "Cephalalgia",

issn = "0333-1024",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "9",

}

TY - JOUR

T1 - On the methodology of drug trials in migraine with aura

AU - Hauge, Anne Werner

AU - Hougaard, Anders

AU - Olesen, Jes

PY - 2010/9/1

Y1 - 2010/9/1

N2 - INTRODUCTION: Specific problems occur in clinical treatment trials for migraine with aura that differ from those encountered in treatment trials for migraine without aura. DISCUSSION: Based on our experience with four such trials, we point to a number of possible solutions and outline areas for future inquiry. We make recommendations about subject selection; the choice, definition and assessment of outcome measures; optimal treatments in relation to aura and headache; and we provide samples of study report forms used to record occurrence of aura and headache in this population.

AB - INTRODUCTION: Specific problems occur in clinical treatment trials for migraine with aura that differ from those encountered in treatment trials for migraine without aura. DISCUSSION: Based on our experience with four such trials, we point to a number of possible solutions and outline areas for future inquiry. We make recommendations about subject selection; the choice, definition and assessment of outcome measures; optimal treatments in relation to aura and headache; and we provide samples of study report forms used to record occurrence of aura and headache in this population.

U2 - 10.1177/0333102409359091

DO - 10.1177/0333102409359091

M3 - Journal article

C2 - 20713554

SN - 0333-1024

VL - 30

SP - 1041

EP - 1048

JO - Cephalalgia

JF - Cephalalgia

IS - 9

ER -

On the methodology of drug trials in migraine with aura

Abstract

Access to Document

Fingerprint

Cite this